Short‐term Preoperative Denosumab With Surgery in Unresectable or Recurrent Giant Cell Tumor of Bone

OBJECTIVE: The purpose of this retrospective study was to evaluate the clinical and oncological results of combination treatment of short‐term preoperative denosumab (the receptor activator of nuclear factor kappa‐B ligand inhibitor) with surgery in unresectable or recurrent cases of giant cell tumo...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Run‐zi, Ma, Tian‐xiao, Qi, Dian‐wen, Zhao, Ming, Hu, Tongyu, Zhang, Guo‐chuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2019
Materias:
Clinical Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6904587/
https://www.ncbi.nlm.nih.gov/pubmed/31762217
http://dx.doi.org/10.1111/os.12561

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6904587/
https://www.ncbi.nlm.nih.gov/pubmed/31762217
http://dx.doi.org/10.1111/os.12561

Ejemplares similares